- Home
- MORN vs ROIV Comparison
MORN vs ROIV Comparison
Compare MORN & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MORN
- ROIV
- Stock Information
- Founded
- MORN 1984
- ROIV 2014
- Country
- MORN United States
- ROIV United Kingdom
- Employees
- MORN N/A
- ROIV N/A
- Industry
- MORN Investment Managers
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- MORN Finance
- ROIV Health Care
- Exchange
- MORN Nasdaq
- ROIV Nasdaq
- Market Cap
- MORN 9.5B
- ROIV 8.6B
- IPO Year
- MORN 2005
- ROIV N/A
- Fundamental
- Price
- MORN $227.60
- ROIV $16.05
- Analyst Decision
- MORN Buy
- ROIV Strong Buy
- Analyst Count
- MORN 3
- ROIV 8
- Target Price
- MORN $361.67
- ROIV $19.94
- AVG Volume (30 Days)
- MORN 528.0K
- ROIV 9.1M
- Earning Date
- MORN 10-29-2025
- ROIV 11-11-2025
- Dividend Yield
- MORN 0.80%
- ROIV N/A
- EPS Growth
- MORN 64.83
- ROIV N/A
- EPS
- MORN 9.41
- ROIV N/A
- Revenue
- MORN $2,347,400,000.00
- ROIV $23,233,000.00
- Revenue This Year
- MORN $8.04
- ROIV N/A
- Revenue Next Year
- MORN $7.65
- ROIV $248.22
- P/E Ratio
- MORN $24.27
- ROIV N/A
- Revenue Growth
- MORN 8.23
- ROIV N/A
- 52 Week Low
- MORN $221.02
- ROIV $8.73
- 52 Week High
- MORN $365.00
- ROIV $16.79
- Technical
- Relative Strength Index (RSI)
- MORN 27.33
- ROIV 77.85
- Support Level
- MORN $221.02
- ROIV $15.25
- Resistance Level
- MORN $238.04
- ROIV $16.79
- Average True Range (ATR)
- MORN 4.61
- ROIV 0.44
- MACD
- MORN -0.10
- ROIV 0.03
- Stochastic Oscillator
- MORN 22.38
- ROIV 72.93
About MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.